Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Wellnex Life Ltd ( (AU:WNX) ) has shared an announcement.
Wellnex Life Ltd has reported positive initial results from its turnaround strategy, focusing on scaling up the Pain Away brand and enhancing contract manufacturing revenues. The company achieved an EBITDA profit of $0.1 million in November, with year-to-date improvements in sales growth and gross margins. The introduction of Pain Away into major retailers like Costco and 7Eleven has boosted sales by 16%, and the company is on track to reach breakeven by Q2 FY2026. The board remains optimistic about further margin improvements and cost reductions in the upcoming quarters.
The most recent analyst rating on (AU:WNX) stock is a Sell with a A$0.16 price target. To see the full list of analyst forecasts on Wellnex Life Ltd stock, see the AU:WNX Stock Forecast page.
More about Wellnex Life Ltd
Wellnex Life Ltd operates in the health and wellness industry, focusing on the development and distribution of health products. The company is primarily known for its Pain Away brand and is engaged in contract manufacturing, aiming to expand its market presence and improve operational efficiency.
Average Trading Volume: 58,264
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$8.74M
Learn more about WNX stock on TipRanks’ Stock Analysis page.